Market capitalization | JPY308.10b |
Enterprise Value | JPY747.86b |
P/E (TTM) P/E ratio | negative |
EV/Sales (TTM) EV/Sales | 0.70 |
P/S ratio (TTM) P/S ratio | 0.29 |
P/B ratio (TTM) P/B ratio | 0.84 |
Dividend yield | 3.07% |
Last dividend (FY24) | JPY100.00 |
Revenue growth (TTM) Revenue growth | 2.32% |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
3 Analysts have issued a Dainippon Ink and Chemicals forecast:
3 Analysts have issued a Dainippon Ink and Chemicals forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,064,784 1,064,784 |
2%
2%
|
|
Gross Profit | 214,729 214,729 |
16%
16%
|
|
EBITDA | 92,638 92,638 |
28%
28%
|
EBIT (Operating Income) EBIT | 38,809 38,809 |
94%
94%
|
Net Profit | -26,468 -26,468 |
796%
796%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DIC Corp. engages in the manufacture and sale of printing inks, organic pigments, and synthetic resins. It operates through the following segments: Packaging and Graphic, Color and Display, Functional Products, and Others. The Packaging and Graphic segment sells gravure, flexographic, security, offset and news inks, packaging adhesives, polystyrene, and coextruded multilayer films. The Color and Display segment includes products such as organic pigments, health food, natural colorants, and thin-film-transistor liquid-crystal display (TFT LCD). The Functional Products segment offers water-based, acrylic, epoxy, polyester and phenolic resins, Sulphur chemicals, magnetic tapes, and molded plastic products. The Others segment handles other products not mentioned in the above segments. The company was founded on February 15, 1908 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Takashi Ikeda |
Employees | 22,255 |
Founded | 1908 |
Website | www.dic-global.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.